Literature DB >> 27941377

68Ga-PSMA PET/CT Imaging in Multiple Myeloma.

Arun Sasikumar1, Ajith Joy, M R A Pillai, Raviteja Nanabala, Boben Thomas.   

Abstract

The potential applications of Ga-labeled prostate-specific membrane antigen (PSMA) PET/CT in the imaging of prostate cancer are now well established. A few case reports regarding the potential use of Ga-PSMA PET/CT in nonprostate cancer malignancies are also published. Apparently, the tumor neoangiogenesis is the mechanism attributed to increased Ga-PSMA uptake in the tumor sites in nonprostatic malignancies. We describe the use of Ga-PSMA PET/CT in imaging multiple myeloma. The intense Ga-PSMA avidity of the lesions also opens up the possibility of theranostics with Lu-PSMA.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27941377     DOI： 10.1097/RLU.0000000000001479

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  9 in total

Review 1.  Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.

Authors:  Philipp Backhaus; Benjamin Noto; Nemanja Avramovic; Lena Sophie Grubert; Sebastian Huss; Martin Bögemann; Lars Stegger; Matthias Weckesser; Michael Schäfers; Kambiz Rahbar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-01-15       Impact factor: 9.236

Review 2.  Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Authors:  Sara Sheikhbahaei; Ali Afshar-Oromieh; Matthias Eiber; Lilja B Solnes; Mehrbod S Javadi; Ashley E Ross; Kenneth J Pienta; Mohamad E Allaf; Uwe Haberkorn; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-01       Impact factor: 9.236

Review 3.  Positron Emission Tomography (PET) Imaging of Multiple Myeloma in a Post-Treatment Setting.

Authors:  Giulia Ferrarazzo; Silvia Chiola; Selene Capitanio; Maria Isabella Donegani; Alberto Miceli; Stefano Raffa; Alberto Stefano Tagliafico; Silvia Morbelli; Matteo Bauckneht
Journal:  Diagnostics (Basel)       Date:  2021-02-03

4.  An overview on prostate-specific membrane antigen uptake in malignancies other than prostate cancer: A pictorial essay.

Authors:  Esmail Jafari; Hojjat Ahmadzadehfar; Habibollah Dadgar; Majid Assadi
Journal:  World J Nucl Med       Date:  2020-07-22

5.  Non-prostate uptake on 18F-PSMA-1007 PET/CT: a case of myeloma.

Authors:  Sowmya Veerasuri; Stewart Redman; Richard Graham; Chris Meehan; David Little
Journal:  BJR Case Rep       Date:  2020-11-03

6.  Demonstration of 68Ga-prostate-specific Membrane Antigen Uptake in Metastatic Pancreatic Neuroendocrine Tumor.

Authors:  Meghana Prabhu; Nishikant Avinash Damle; Ravikant Gupta; Saurabh Arora; Sreedharan Thankarajan Arunraj; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2018 Jul-Sep

7.  Prostate-specific Membrane Antigen Imaging in Recurrent Medullary Thyroid Cancer: A New Theranostic Tracer in the Offing?

Authors:  Saurabh Arora; Meghana Prabhu; Nishikant Avinash Damle; Chandrasekhar Bal; Praveen Kumar; Harish Nalla; Sreedharan Thankarajan Arun Raj
Journal:  Indian J Nucl Med       Date:  2018 Jul-Sep

Review 8.  Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.

Authors:  Silvia Valtorta; Daniela Salvatore; Paolo Rainone; Sara Belloli; Gloria Bertoli; Rosa Maria Moresco
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

9.  Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on 18F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression.

Authors:  Lena M Mittlmeier; Stephan T Ledderose; Melanie Schott; Matthias Brendel; Leonie Beyer; Sebastian Theurich; Doris Mayr; Christoph Walz; Wolfgang G Kunz; Jens Ricke; Peter Bartenstein; Harun Ilhan; Michael Staehler; Marcus Unterrainer
Journal:  Diagnostics (Basel)       Date:  2021-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.